AR080321A1 -
A COMPOSITION OF PROLONGED PHARMACEUTICAL RELEASE OF ENTACAPONA OR ITS SALTS, PREPARATION PROCESS AND METHOD OF TREATMENT OF PARKINSON'S DISEASE
- Google Patents
A COMPOSITION OF PROLONGED PHARMACEUTICAL RELEASE OF ENTACAPONA OR ITS SALTS, PREPARATION PROCESS AND METHOD OF TREATMENT OF PARKINSON'S DISEASE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Research CenterfiledCriticalWockhardt Research Center
Priority to ARP110100595priorityCriticalpatent/AR080321A1/en
Publication of AR080321A1publicationCriticalpatent/AR080321A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Reivindicacion 1: Una composicion farmacéutica que comprende de 200 a 1000 mg de entacapona o sus sales, opcionalmente con otros excipientes farmacéuticamente aceptables. Reivindicacion 12: Una composicion farmacéutica que comprende alrededor de 30 mg a 300 mg de levodopa, 10 mg a 100 mg de carbidopa y 200 mg a cerca de 1000 mg de entacapona o sus sales, opcionalmente con otros excipientes farmacéuticamente aceptables.Claim 1: A pharmaceutical composition comprising 200 to 1000 mg of entacapone or its salts, optionally with other pharmaceutically acceptable excipients. Claim 12: A pharmaceutical composition comprising about 30 mg to 300 mg of levodopa, 10 mg to 100 mg of carbidopa and 200 mg to about 1000 mg of entacapone or its salts, optionally with other pharmaceutically acceptable excipients.
ARP1101005952011-02-252011-02-25
A COMPOSITION OF PROLONGED PHARMACEUTICAL RELEASE OF ENTACAPONA OR ITS SALTS, PREPARATION PROCESS AND METHOD OF TREATMENT OF PARKINSON'S DISEASE
AR080321A1
(en)
DPP-4 INHIBITOR IN A COMBINATION WITH AN ADDITIONAL ANTI-DIABETIC AGENT, TABLETS INCLUDING THE SPECIFIED COMPOSITIONS, THEIR APPLICATION AND METHOD OF THEIR PRODUCTION
A method of treating a subject comprising administering optionally deuterated n-ethyl-n-phenyl1,2-dihydroxy-4-hodroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, for the treatment of a disease autoimmune; a mixture thereof; Pharmaceutical composition and its preparation process.
3'-n-desmethyl-4 '' - o- (2-diethylaminoetanoyl) -6-o-methyl-9a-aza-9a-homoerythromycin a, its salts and crystalline forms 1, 2 and 3; Preparation process; use to treat inflammatory diseases; pharmaceutical composition; and composition which also comprises another active compound.
STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS
3-carboxy-n-ethyl-n, n-dimethylpropan-1-ammonium salts (2e) -3-carboxy acrylate, phosphatodihydrogen and 2,6-diohydyl-1,2,3,6-tetrahydropyrimidine-4-carboxylate; preparation procedure; and use in the treatment of cardiovascular diseases.